Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02203760
Title Pazopanib vs. Pazopanib Plus Gemcitabine (PazoDoble)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Indications

uterus leiomyosarcoma

uterine carcinosarcoma

Therapies

Pazopanib

Gemcitabine + Pazopanib

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.